T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$2.6B |
| 2 |
BNY
Bank of New York Mellon
BNY
|
+$1.1B |
| 3 |
Elevance Health
ELV
|
+$903M |
| 4 |
DD
Du Pont De Nemours E I
DD
|
+$873M |
| 5 |
Medtronic
MDT
|
+$868M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan Inc
AGN
|
+$3.89B |
| 2 |
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
|
+$1.06B |
| 3 |
CFN
CAREFUSION CORPORATION
CFN
|
+$946M |
| 4 |
Aptiv
APTV
|
+$886M |
| 5 |
KSU
Kansas City Southern
KSU
|
+$662M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 21.05% |
| 2 | Consumer Discretionary | 13.82% |
| 3 | Financials | 13.14% |
| 4 | Industrials | 11.9% |
| 5 | Technology | 9.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CLNY
1176
DELISTED
Colony Capital, Inc.
CLNY
| $17.4M | ﹤0.01% |
669,840
-5,410
| -0.8% | -$136K |
|
1177
PTC
PTC
$16.7B
| $17.2M | ﹤0.01% |
474,454
+26,738
| +6% | +$923K |
|
|
SIX
1178
DELISTED
Six Flags Entertainment Corp.
SIX
| $17.2M | ﹤0.01% |
354,500
-10,500
| -3% | -$478K |
|
|
SEE
1179
DELISTED
Sealed Air
SEE
| $16.9M | ﹤0.01% |
371,731
+29,400
| +9% | +$1.3M |
|
1180
Casey's General Stores
CASY
$31.6B
| $16.9M | ﹤0.01% |
187,500
+164,500
| +715% | +$14.8M |
|
|
UAM
1181
DELISTED
Universal American Corp
UAM
| $16.6M | ﹤0.01% |
1,550,020
+1,535,680
| +10,709% | +$14.4M |
|
|
VAR
1182
DELISTED
Varian Medical Systems, Inc.
VAR
| $16.4M | ﹤0.01% |
199,088
+16,764
| +9% | +$1.35M |
|
|
CPN
1183
DELISTED
Calpine Corporation
CPN
| $16.3M | ﹤0.01% |
714,569
-4,363,281
| -86% | -$94.1M |
|
1184
D.R. Horton
DHI
$41.9B
| $16.3M | ﹤0.01% |
572,170
+10,400
| +2% | +$271K |
|
|
CBK
1185
DELISTED
Christopher & Banks Corporation
CBK
| $16.2M | ﹤0.01% |
2,920,237
-44,400
| -1% | -$236K |
|
|
ARAV
1186
DELISTED
Aravive, Inc. Common Stock
ARAV
| $16.2M | ﹤0.01% |
146,533
+75,416
| +106% | +$8.85M |
|
1187
Fluor
FLR
$7B
| $16.1M | ﹤0.01% |
281,964
-2,022
| -0.7% | -$115K |
|
1188
PRA Group
PRAA
$762M
| $16.1M | ﹤0.01% |
296,650
+9,100
| +3% | +$486K |
|
|
XOXO
1189
DELISTED
Xo Group Inc
XOXO
| $16M | ﹤0.01% |
906,990
+3,800
| +0.4% | +$64.3K |
|
1190
Fortune Brands Innovations
FBIN
$5.78B
| $15.9M | ﹤0.01% |
392,437
-8,561
| -2% | -$333K |
|
1191
Generac Holdings
GNRC
$12.8B
| $15.8M | ﹤0.01% |
324,765
-98,472
| -23% | -$4.69M |
|
1192
BlackRock TCP Capital
TCPC
$353M
| $15.8M | ﹤0.01% |
984,905
-8,020
| -0.8% | -$129K |
|
1193
Rollins
ROL
$17.4B
| $15.7M | ﹤0.01% |
1,432,631
+240,861
| +20% | +$2.43M |
|
|
CRR
1194
DELISTED
Carbo Ceramics Inc.
CRR
| $15.7M | ﹤0.01% |
515,523
-16,272
| -3% | -$571K |
|
1195
Expedia Group
EXPE
$39.4B
| $15.6M | ﹤0.01% |
166,237
+2,990
| +2% | +$265K |
|
|
SWN
1196
DELISTED
Southwestern Energy Company
SWN
| $15.6M | ﹤0.01% |
672,585
+70,810
| +12% | +$1.76M |
|
1197
World Kinect Corp
WKC
$1.9B
| $15.6M | ﹤0.01% |
270,600
+247,700
| +1,082% | +$12.9M |
|
|
PTLA
1198
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
| $15.5M | ﹤0.01% |
409,079
-20,896
| -5% | -$718K |
|
|
AXE
1199
DELISTED
Anixter International Inc
AXE
| $15.5M | ﹤0.01% |
203,900
-1,900
| -0.9% | -$148K |
|
1200
United Rentals
URI
$69.7B
| $15.5M | ﹤0.01% |
169,570
+16,790
| +11% | +$1.51M |
|
Similar funds
T. Rowe Price Associates's Q1 2015 Portfolio in Review
As of Q1 2015, T. Rowe Price Associates held 2,630 positions worth $484B, up 2.8% from $471B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
T. Rowe Price Associates's Q1 2015 filing shows 93 new, 1,078 increased, 887 reduced and 93 closed positions. Its largest new stake was ACTAVIS PLC Pfd Conv Ser A (Irl): 516,600 shares worth $532M. The largest sale was Allergan Inc, an estimated $3.89B.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 20% a quarter earlier, followed by Consumer Discretionary and Financials.
- T. Rowe Price Associates's largest Q1 2015 buy was ACTAVIS PLC Pfd Conv Ser A (Irl): 516,600 shares worth $532M.
- T. Rowe Price Associates added most to Allergan plc in Q1 2015, an estimated $2.6B increase.
- T. Rowe Price Associates's biggest Q1 2015 reduction was Aptiv, cutting an estimated $886M.
- T. Rowe Price Associates fully exited Allergan Inc in Q1 2015, selling an estimated $3.89B.
- T. Rowe Price Associates's ten largest holdings make up 13% of its $484B portfolio in Q1 2015.
- T. Rowe Price Associates opened 93 new positions and closed 93 in Q1 2015.
- T. Rowe Price Associates's portfolio value rose 2.8% quarter-over-quarter to $484B.
Based on T. Rowe Price Associates's 13F filing for Q1 2015, filed 15 May 2015.